Letter From the Editor: Traveling With Inflammatory Bowel Disease?

摘要

One of our feature articles this month focuses on current and future therapeutic approaches for chronic hepatitis D. Dr Patrizia Farci and Dr Grazia Anna Niro highlight the unconventional nature of hepatitis D virus, current management with standard or pegylated interferon-α, and how new insights from the life cycle of this virus have resulted in the emergence of novel drug classes presently being investigated (ie, sodium taurocholate cotransporting polypeptide receptor inhibitors, farnesyltransferase inhibitors, and nucleic acid polymers).?